RTTNews | Dec 11, 2020 09:48AM EST

09:47 Friday, December 11, 2020 (RTTNews.com) - Shares of Sonoma Pharmaceuticals, Inc. (SNOA) are surging over 100% on Friday morning. The pharma company has teamed up with Crown Laboratories to launch Microcyn technology-based anti-itch over-the-counter products.

SNOA is currently trading at $12.54, up $6.34 or 102.22%, on the Nasdaq.

Sonoma and Crown announce they have entered into a license and supply agreement for the exclusive rights to sell and market products for the OTC dermatological market in the US.

Crown plans to sell Sonoma's Microcyn technology dermal sprays and gels targeting itch and pain under Sarna brand.

Read the original article on RTTNews ( https://www.rttnews.com/3153088/stock-alert-sonoma-pharmaceuticals-more-than-doubles.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved